Advanced search
Start date

Vel system: molecular Screening using DNA obtained from plasma pools of blood donors

Grant number: 15/09540-3
Support Opportunities:Scholarships in Brazil - Master
Effective date (Start): October 01, 2015
Effective date (End): November 20, 2016
Field of knowledge:Health Sciences - Collective Health - Preventive Medicine
Principal Investigator:José Eduardo Levi
Grantee:Marcia Regina Dezan
Host Institution: Hemocentro de São Paulo. Fundação Pró-Sangue. Secretaria da Saúde (São Paulo - Estado). São Paulo , SP, Brazil


Patients on chronic transfusion regime, has a high rate of alloimmunization erythrocyte, which is associated with tranfusionais hemolytic reactions. When there is formation of multiple alloantibodies or alloantibodies against high population frequency antigens, only donors with rare or unusual blood phenotypes can meet these receptors. The search for these donors may be performed by serological or molecular methods. In this sphere, genotyping technique for real-time DNA pools is a promising strategy due to operational optimization, the accuracy of the results and the low cost of the reaction.This project aims to screen DNA samples from blood donors obtained from plasma pools (six donors per pool) using the PCR technology in real time to detect carriers of polymorphisms encoding the rare phenotype negative Vel, antigen high frequency of clinical importance in practice transfusion. DNA samples extracted will be used for the realization of NAT testing for HIV and HCV research, which is required by Brazilian law and whose extracted material is discarded after achieving this.Population studies estimate the frequency of negative Vel individuals than 1 in 4,000 in Europe and slightly higher in northern Scandinavia, 1 in 1,700 (Storry et al, 2013). In Brazil, this frequency is not known.

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Please report errors in scientific publications list by writing to: